Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines

Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines

US Patent 9057716 · Granted Jun 16, 2015

Estimated economic value: $16,215,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Meningococcus vaccines2025
Vaccines for Neisseria gonorrhoeae2024
Meningococcus vaccines2023
Vitro potency assay for protein-based meningococcal vaccines2021
Vitro potency assay for protein-based meningococcal vaccines2021
In vitro potency assay for protein-based meningococcal vaccines2020
In vitro potency assay for protein-based meningococcal vaccines2020
Vaccines for serogroup X meningococcus2019
Immunising against meningococcal serogroup Y using proteins2019
Compositions comprising Neisseria meningitidis antigens from serogroups B and C2017
Combination neisserial compositions2017
Meningococcal fHBP polypeptides2017